These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

854 related items for PubMed ID: 12209745

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Differential cyclooxygenase-2 expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix.
    Kim YB, Kim GE, Pyo HR, Cho NH, Keum KC, Lee CG, Seong J, Suh CO, Park TK.
    Int J Radiat Oncol Biol Phys; 2004 Nov 01; 60(3):822-9. PubMed ID: 15465199
    [Abstract] [Full Text] [Related]

  • 3. Coexpression of cyclooxygenase-2 and thymidine phosphorylase as a prognostic indicator in patients with FIGO stage IIB squamous cell carcinoma of uterine cervix treated with radiotherapy and concurrent chemotherapy.
    Pyo H, Kim YB, Cho NH, Suh CO, Park TK, Yun YS, Kim GE.
    Int J Radiat Oncol Biol Phys; 2005 Jul 01; 62(3):725-32. PubMed ID: 15936552
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Predictive factor of distant recurrence in locally advanced squamous cell carcinoma of the cervix treated with concurrent chemoradiotherapy.
    Hirakawa M, Nagai Y, Inamine M, Kamiyama K, Ogawa K, Toita T, Murayama S, Aoki Y.
    Gynecol Oncol; 2008 Jan 01; 108(1):126-9. PubMed ID: 17936344
    [Abstract] [Full Text] [Related]

  • 6. Risk stratification of patients with advanced squamous cell carcinoma of cervix treated by radiotherapy alone.
    Hong JH, Tsai CS, Lai CH, Chang TC, Wang CC, Chou HH, Lee SP, Lee CC, Tang SG, Hsueh S.
    Int J Radiat Oncol Biol Phys; 2005 Oct 01; 63(2):492-9. PubMed ID: 15925454
    [Abstract] [Full Text] [Related]

  • 7. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
    Juang CM, Wang PH, Yen MS, Lai CR, Ng HT, Yuan CC.
    Gynecol Oncol; 2000 Jan 01; 76(1):103-6. PubMed ID: 10620449
    [Abstract] [Full Text] [Related]

  • 8. Prognostic factors in neuroendocrine small cell cervical carcinoma: a multivariate analysis.
    Chan JK, Loizzi V, Burger RA, Rutgers J, Monk BJ.
    Cancer; 2003 Feb 01; 97(3):568-74. PubMed ID: 12548598
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Tissue microarray analysis reveals prognostic significance of COX-2 expression for local relapse in T1-2N0 larynx cancer treated with primary radiation therapy.
    Cho EI, Kowalski DP, Sasaki CT, Haffty BG.
    Laryngoscope; 2004 Nov 01; 114(11):2001-8. PubMed ID: 15510031
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prediction of poor survival by cyclooxygenase-2 in patients with T4 nasopharyngeal cancer treated by radiation therapy: clinical and in vitro studies.
    Chen WC, McBride WH, Chen SM, Lee KF, Hwang TZ, Jung SM, Shau H, Liao SK, Hong JH, Chen MF.
    Head Neck; 2005 Jun 01; 27(6):503-12. PubMed ID: 15772955
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Estimation of treatment results and side-effects in patients with invasive uterine cervix cancer stage IIB-IVA treated with concurrent radiochemotherapy].
    Torbé B.
    Ann Acad Med Stetin; 2008 Jun 01; 54(1):28-40. PubMed ID: 19127807
    [Abstract] [Full Text] [Related]

  • 17. Overexpression of cyclooxygenase-2 protein and its relationship to apoptosis in cervical carcinoma treated with neoadjuvant chemotherapy.
    Nagai N, Tian X, Mukai K, Hirata E, Kusuda T, Shiroyama Y, Shigemasa K, Ohama K.
    Int J Mol Med; 2003 Nov 01; 12(5):709-14. PubMed ID: 14532998
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma.
    Denkert C, Winzer KJ, Müller BM, Weichert W, Pest S, Köbel M, Kristiansen G, Reles A, Siegert A, Guski H, Hauptmann S.
    Cancer; 2003 Jun 15; 97(12):2978-87. PubMed ID: 12784332
    [Abstract] [Full Text] [Related]

  • 20. Increased expression of nitric oxide synthase and cyclooxygenase-2 is associated with poor survival in cervical cancer treated with radiotherapy.
    Chen HH, Su WC, Chou CY, Guo HR, Ho SY, Que J, Lee WY.
    Int J Radiat Oncol Biol Phys; 2005 Nov 15; 63(4):1093-100. PubMed ID: 16099602
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.